Propentofylline prevents sickness behavior and depressive-like behavior induced by lipopolysaccharide in rats via neuroinflammatory pathway

PLoS ONE

Volumn 12, Issue 1, 2017, Pages

  Moraes, MaÂrcia M T ^a   Galvão, Marcella C ^b   Cabral, Danilo ^a   Coelho, Cideli P ^c   Queiroz Hazarbassanov, Nicolle ^b   Martins, Maria F M ^a   Bondan, Eduardo F ^a   Bernardi, Maria M ^a   Kirsten, Thiago Berti ^a,b  

^a PAULISTA UNIVERSITY   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c UNIVERSITY OF SANTO AMARO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; GLIAL FIBRILLARY ACIDIC PROTEIN; LIPOPOLYSACCHARIDE; PROPENTOFYLLINE; TUMOR NECROSIS FACTOR; ANTIDEPRESSANT AGENT; GLIAL FIBRILLARY ACID PROTEIN, RAT; XANTHINE DERIVATIVE;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY DISORDER; ARTICLE; BEHAVIOR DISORDER; CLIMBING; CONTROLLED STUDY; DEPRESSION; ILLNESS BEHAVIOR; IMMOBILITY; LOCOMOTION; MALE; NERVOUS SYSTEM INFLAMMATION; NONHUMAN; OPEN FIELD BEHAVIOR; PROPHYLAXIS; PROTEIN BLOOD LEVEL; RAT; REARING; WEIGHT REDUCTION; ANIMAL; ANIMAL BEHAVIOR; ANXIETY; BODY WEIGHT; DEPRESSIVE DISORDER; DISEASE MODEL; DRUG EFFECTS; IMMUNOHISTOCHEMISTRY; METABOLISM; MICROPHOTOGRAPHY; WISTAR RAT;

ANIMALS; ANTIDEPRESSIVE AGENTS; ANXIETY; BEHAVIOR, ANIMAL; BODY WEIGHT; BRAIN-DERIVED NEUROTROPHIC FACTOR; DEPRESSION; DEPRESSIVE DISORDER; DISEASE MODELS, ANIMAL; GLIAL FIBRILLARY ACIDIC PROTEIN; ILLNESS BEHAVIOR; IMMUNOHISTOCHEMISTRY; LIPOPOLYSACCHARIDES; MALE; PHOTOMICROGRAPHY; RATS; RATS, WISTAR; TUMOR NECROSIS FACTOR-ALPHA; XANTHINES;

EID: 85008675439     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0169446     Document Type: Article

References (59)

1. Thompson C, Ostler K, Peveler RC, Baker N, Kinmonth AL. Dimensional perspective on the recognition of depressive symptoms in primary care: The Hampshire Depression Project 3. Br J Psychiatry. 2001; 179:317-23. Epub 2001/10/03. PMID: 11581111.
2. Carroll LJ, Cassidy JD, Cote P. Factors associated with the onset of an episode of depressive symptoms in the general population. J Clin Epidemiol. 2003; 56(7):651-8. Epub 2003/08/19. S0895435603001185 [pii]. PMID: 12921934.
3. Clark DC. Suicide risk assessment and prediction in the 1990s. Crisis. 1990; 11(2):104-12. Epub 1990/11/01. PMID: 2076610.
4. Lonnqvist JK, Henriksson MM, Isometsa ET, Marttunen MJ, Heikkinen ME, Aro HM, et al. Mental disorders and suicide prevention. Psychiatry Clin Neurosci. 1995; 49 Suppl 1:S111-6. Epub 1995/05/01.
5. Parker G, Brotchie H. Gender differences in depression. Int Rev Psychiatry. 2010; 22(5):429-36. Epub 2010/11/05. doi:10.3109/09540261.2010.492391 PMID: 21047157.
6. Murray CJ, Lopez AD. Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study. Lancet. 1997; 349(9063):1436-42. Epub 1997/05/17. S0140-6736(96)07495-8 [pii] doi:10.1016/S0140-6736(96)07495-8 PMID: 9164317.
7. Jenkins E, Goldner EM. Approaches to understanding and addressing treatment-resistant depression: A scoping review. Depress Res Treat. 2012; 2012:469680. Epub 2012/05/10. PubMed Central PMCID: PMC3337614. doi:10.1155/2012/469680PMID: 22570778.
8. Colman I, Ataullahjan A. Life course perspectives on the epidemiology of depression. Can J Psychiatry. 2010; 55(10):622-32. Epub 2010/10/23. PMID: 20964941.
9. Raedler TJ. Inflammatory mechanisms in major depressive disorder. Curr Opin Psychiatry. 2011; 24 (6):519-25. Epub 2011/09/08. doi:10.1097/YCO.0b013e32834b9db6 PMID: 21897249.
10. Smith RS. The macrophage theory of depression. Med Hypotheses. 1991; 35(4):298-306. Epub 1991/08/01. PMID: 1943879.
11. Dowlati Y, Herrmann N, Swardfager W, Liu H, Sham L, Reim EK, et al. A meta-Analysis of cytokines in major depression. Biol Psychiatry. 2010; 67(5):446-57. Epub 2009/12/18. S0006-3223(09)01229-3 [pii]. doi:10.1016/j.biopsych.2009.09.033 PMID: 20015486.
12. Loftis JM, Hauser P. The phenomenology and treatment of interferon-induced depression. J Affect Disord. 2004; 82(2):175-90. Epub 2004/10/19. S0165032704001442 [pii]. doi:10.1016/j.jad.2004.04.002 PMID: 15488246.
13. Eisenberger NI, Inagaki TK, Mashal NM, Irwin MR. Inflammation and social experience: An inflammatory challenge induces feelings of social disconnection in addition to depressed mood. Brain Behav Immun. 2010; 24(4):558-63. Epub 2010/01/02. S0889-1591(09)00564-9 [pii]. PubMed Central PMCID: PMC2856755. doi:10.1016/j.bbi.2009.12.009 PMID: 20043983.
14. Hava G, Vered L, Yael M, Mordechai H, Mahoud H. Alterations in behavior in adult offspring mice following maternal inflammation during pregnancy. Dev Psychobiol. 2006; 48(2):162-8. doi:10.1002/dev.20116 PMID: 16489598.
15. Aderem A, Ulevitch RJ. Toll-like receptors in the induction of the innate immune response. Nature. 2000; 406(6797):782-7. doi:10.1038/35021228 PMID: 10963608.
16. Kirsten TB, Lippi LL, Bevilacqua E, Bernardi MM. LPS exposure increases maternal corticosterone levels, causes placental injury and increases IL-1β levels in adult rat offspring: Relevance to autism. PLoS One. 2013; 8(12):e82244. doi:10.1371/journal.pone.0082244 PMID: 24312647.
17. Muller N, Schwarz MJ, Dehning S, Douhe A, Cerovecki A, Goldstein-Muller B, et al. The cyclooxygenase- 2 inhibitor celecoxib has therapeutic effects in major depression: Results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine. Mol Psychiatry. 2006; 11(7):680-4. Epub 2006/02/24. 4001805 [pii] doi:10.1038/sj.mp.4001805PMID: 16491133.
18. Akhondzadeh S, Jafari S, Raisi F, Nasehi AA, Ghoreishi A, Salehi B, et al. Clinical trial of adjunctive celecoxib treatment in patients with major depression: A double blind and placebo controlled trial. Depress Anxiety. 2009; 26(7):607-11. Epub 2009/06/06. doi:10.1002/da.20589PMID: 19496103.
19. Tyring S, Gottlieb A, Papp K, Gordon K, Leonardi C, Wang A, et al. Etanercept and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebo-controlled randomised phase III trial. Lancet. 2006; 367(9504):29-35. Epub 2006/01/10. S0140-6736(05)67763-X [pii]. doi:10.1016/S0140-6736(05)67763-X PMID: 16399150.
20. Persoons P, Vermeire S, Demyttenaere K, Fischler B, Vandenberghe J, Van Oudenhove L, et al. The impact of major depressive disorder on the short-And long-Term outcome of Crohn's disease treatment with infliximab. Aliment Pharmacol Ther. 2005; 22(2):101-10. Epub 2005/07/14. APT2535 [pii]. doi:10.1111/j.1365-2036.2005.02535.x PMID: 16011668.
21. Sweitzer S, De Leo J. Propentofylline: glial modulation, neuroprotection, and alleviation of chronic pain. Handb Exp Pharmacol. 2011;(200):235-50. Epub 2010/09/23. doi:10.1007/978-3-642-13443-2-8 PMID: 20859798.
22. Bondan EF, Martins Mde F, Menezes Baliellas DE, Monteiro Gimenez CF, Castro Poppe S, Martha Bernardi M. Effects of propentofylline on CNS remyelination in the rat brainstem. Microsc Res Tech. 2014; 77(1):23-30. Epub 2013/11/05. doi:10.1002/jemt.22308PMID: 24185688.
23. Jung S, Donhauser T, Toyka KV, Hartung HP. Propentofylline and iloprost suppress the production of TNF-Alpha by macrophages but fail to ameliorate experimental autoimmune encephalomyelitis in Lewis rats. J Autoimmun. 1997; 10(6):519-29. Epub 1998/02/06. S0896-8411(97)90159-1 [pii]. doi:10.1006/jaut.1997.0159PMID: 9451591.
24. Bay-Richter C, Janelidze S, Hallberg L, Brundin L. Changes in behaviour and cytokine expression upon a peripheral immune challenge. Behav Brain Res. 2011; 222(1):193-9. Epub 2011/04/07. S0166-4328 (11)00263-4 [pii]. doi:10.1016/j.bbr.2011.03.060 PMID: 21466824.
25. Frenois F, Moreau M, O'Connor J, Lawson M, Micon C, Lestage J, et al. Lipopolysaccharide induces delayed FosB/DeltaFosB immunostaining within the mouse extended amygdala, hippocampus and hypothalamus, that parallel the expression of depressive-like behavior. Psychoneuroendocrinology. 2007; 32(5):516-31. Epub 2007/05/08. S0306-4530(07)00063-7 [pii]. PubMed Central PMCID: PMC1978247. doi:10.1016/j.psyneuen.2007.03.005 PMID: 17482371.
26. Dantzer R, O'Connor JC, Freund GG, Johnson RW, Kelley KW. From inflammation to sickness and depression: When the immune system subjugates the brain. Nat Rev Neurosci. 2008; 9(1):46-56. Epub 2007/12/13. nrn2297 [pii]. PubMed Central PMCID: PMC2919277. doi:10.1038/nrn2297 PMID: 18073775.
27. Yirmiya R. Endotoxin produces a depressive-like episode in rats. Brain Res. 1996; 711(1-2):163-74. Epub 1996/03/04. 0006-8993(95)01415-2 [pii]. PMID: 8680860.
28. Hashimoto K, Shimizu E, Iyo M. Critical role of brain-derived neurotrophic factor in mood disorders. Brain Res Brain Res Rev. 2004; 45(2):104-14. Epub 2004/05/18. S0165017304000189 [pii]. doi:10.1016/j.brainresrev.2004.02.003 PMID: 15145621.
29. Drzyzga LR, Marcinowska A, Obuchowicz E. Antiapoptotic and neurotrophic effects of antidepressants: A review of clinical and experimental studies. Brain Res Bull. 2009; 79(5):248-57. Epub 2009/06/02. S0361-9230(09)00100-2 [pii]. doi:10.1016/j.brainresbull.2009.03.009 PMID: 19480984.
30. Petzold A. Glial fibrillary acidic protein is a body fluid biomarker for glial pathology in human disease. Brain Res. 2015; 1600:17-31. Epub 2014/12/30. S0006-8993(14)01711-9 [pii]. doi:10.1016/j.brainres.2014.12.027 PMID: 25543069.
31. NCR. National Research Council. Committee for the Update of the Guide for the Care and Use of Laboratory Animals. Guide for the Care and Use of Laboratory Animals. 8th ed. Washington (DC): National Academies Press; 2011. 248 p.
32. Kent S, Bluthe RM, Kelley KW, Dantzer R. Sickness behavior as a new target for drug development. Trends Pharmacol Sci. 1992; 13(1):24-8. PMID: 1542935.
33. Hart BL. Biological basis of the behavior of sick animals. Neurosci Biobehav Rev. 1988; 12(2):123-37. PMID: 3050629.
34. Larson SJ, Dunn AJ. Behavioral effects of cytokines. Brain Behav Immun. 2001; 15(4):371-87. doi:10.1006/brbi.2001.0643 PMID: 11782104.
35. Dantzer R, Kelley KW. Twenty years of research on cytokine-induced sickness behavior. Brain Behav Immun. 2007; 21(2):153-60. doi:10.1016/j.bbi.2006.09.006 PMID: 17088043.
36. Patti CL, Frussa-Filho R, Silva RH, Carvalho RC, Kameda SR, Takatsu-Coleman AL, et al. Behavioral characterization of morphine effects on motor activity in mice. Pharmacol Biochem Behav. 2005; 81 (4):923-7. Epub 2005/08/09. S0091-3057(05)00235-2 [pii]. doi:10.1016/j.pbb.2005.07.004 PMID: 16083952.
37. Campos AC, Fogaca MV, Aguiar DC, Guimaraes FS. Animal models of anxiety disorders and stress. Rev Bras Psiquiatr. 2013; 35 Suppl 2:S101-11. Epub 2013/12/07. S1516-44462013000600006 [pii].
38. Crawley J, Goodwin FK. Preliminary report of a simple animal behavior model for the anxiolytic effects of benzodiazepines. Pharmacol Biochem Behav. 1980; 13(2):167-70. Epub 1980/08/01. PMID: 6106204.
39. Cryan JF, Markou A, Lucki I. Assessing antidepressant activity in rodents: Recent developments and future needs. Trends Pharmacol Sci. 2002; 23(5):238-45. Epub 2002/05/15. S0165-6147(02)02017-5 [pii]. PMID: 12008002.
40. Connor TJ, O'Sullivan J, Nolan Y, Kelly JP. Inhibition of constitutive nitric oxide production increases the severity of lipopolysaccharide-induced sickness behaviour: A role for TNF-Alpha. Neuroimmunomodulation. 2002; 10(6):367-78. Epub 2003/08/09. 71478 71478 [pii]. PMID: 12907844.
41. Farooq RK, Isingrini E, Tanti A, Le Guisquet AM, Arlicot N, Minier F, et al. Is unpredictable chronic mild stress (UCMS) a reliable model to study depression-induced neuroinflammation? Behav Brain Res. 2012; 231(1):130-7. Epub 2012/04/03. S0166-4328(12)00212-4 [pii]. doi:10.1016/j.bbr.2012.03.020PMID: 22465167.
42. Smialowska M, Szewczyk B, Wozniak M, Wawrzak-Wlecial A, Domin H. Glial degeneration as a model of depression. Pharmacol Rep. 2013; 65(6):1572-9. Epub 2014/02/21. PMID: 24553005.
43. Joaquim AO, Coelho CP, Motta PD, Bondan EF, Teodorov E, Martins MF, et al. Transgenerational effects of a hypercaloric diet. Reprod Fertil Dev. 2015. Epub 2015/08/26. RD15165 [pii].
44. Dantzer R. Cytokine, sickness behavior, and depression. Neurologic Clinics. 2006; 24(3):441-60. Epub 2006/08/01. S0733-8619(06)00029-6 [pii]. doi:10.1016/j.ncl.2006.03.003 PMID: 16877117.
45. de Paiva VN, Lima SN, Fernandes MM, Soncini R, Andrade CA, Giusti-Paiva A. Prostaglandins mediate depressive-like behaviour induced by endotoxin in mice. Behav Brain Res. 2010; 215(1):146-51. Epub 2010/07/27. S0166-4328(10)00516-4 [pii]. doi:10.1016/j.bbr.2010.07.015 PMID: 20654654.
46. Soncini R, de Souza DF, Neves AP, Braga DS, Andrade CA, Giusti-Paiva A. Dipyrone attenuates acute sickness response to lipopolysaccharide in mice. Neurosci Lett. 2012; 516(1):114-8. Epub 2012/04/12. S0304-3940(12)00468-5 [pii]. doi:10.1016/j.neulet.2012.03.070 PMID: 22490882.
47. Ribeiro DE, Maiolini VM, Soncini R, Antunes-Rodrigues J, Elias LL, Vilela FC, et al. Inhibition of nitric oxide synthase accentuates endotoxin-induced sickness behavior in mice. Pharmacol Biochem Behav. 2013; 103(3):535-40. Epub 2012/10/11. S0091-3057(12)00280-8 [pii]. doi:10.1016/j.pbb.2012.09.022 PMID: 23046850.
48. Kirsten TB, Galvao MC, Reis-Silva TM, Queiroz-Hazarbassanov N, Bernardi MM. Zinc prevents sickness behavior induced by lipopolysaccharides after a stress challenge in rats. PLoS One. 2015; 10(3): E0120263. Epub 2015/03/17. PONE-D-14-45220 [pii]. PubMed Central PMCID: PMC4361539. doi:10.1371/journal.pone.0120263 PMID: 25775356.
49. Binder DK, Scharfman HE. Brain-derived neurotrophic factor. Growth Factors. 2004; 22(3):123-31. Epub 2004/11/03. PubMed Central PMCID: PMC2504526. doi:10.1080/08977190410001723308 PMID: 15518235.
50. Li N, He X, Zhang Y, Qi X, Li H, Zhu X, et al. Brain-derived neurotrophic factor signalling mediates antidepressant effects of lamotrigine. Int J Neuropsychopharmacol. 2011; 14(8):1091-8. Epub 2010/09/18. S1461145710001082 [pii]. doi:10.1017/S1461145710001082 PMID: 20846461.
51. Katoh-Semba R, Wakako R, Komori T, Shigemi H, Miyazaki N, Ito H, et al. Age-related changes in BDNF protein levels in human serum: differences between autism cases and normal controls. Int J Dev Neurosci. 2007; 25(6):367-72. Epub 2007/09/07. S0736-5748(07)00098-6 [pii]. doi:10.1016/j.ijdevneu.2007.07.002 PMID: 17804189.
52. Karege F, Schwald M, Cisse M. Postnatal developmental profile of brain-derived neurotrophic factor in rat brain and platelets. Neurosci Lett. 2002; 328(3):261-4. Epub 2002/07/31. S0304394002005293 [pii]. PMID: 12147321.
53. Garcia-Caceres C, Yi CX, Tschop MH. Hypothalamic astrocytes in obesity. Endocrinol Metab Clin North Am. 2013; 42(1):57-66. Epub 2013/02/09. S0889-8529(12)00127-2 [pii]. doi:10.1016/j.ecl.2012.11.003 PMID: 23391239.
54. Levine JB, Kong J, Nadler M, Xu Z. Astrocytes interact intimately with degenerating motor neurons in mouse amyotrophic lateral sclerosis (ALS). Glia. 1999; 28(3):215-24. Epub 1999/11/24. PMID: 10559780.
55. Ridet JL, Alonso G, Chauvet N, Chapron J, Koenig J, Privat A. Immunocytochemical characterization of a new marker of fibrous and reactive astrocytes. Cell Tissue Res. 1996; 283(1):39-49. Epub 1996/01/01. PMID: 8581958.
56. Brenner M. Role of GFAP in CNS injuries. Neurosci Lett. 2014; 565:7-13. Epub 2014/02/11. S0304- 3940(14)00090-1 [pii]. PubMed Central PMCID: PMC4049287. doi:10.1016/j.neulet.2014.01.055 PMID: 24508671.
57. Yang Z, Wang KK. Glial fibrillary acidic protein: from intermediate filament assembly and gliosis to neurobiomarker. Trends Neurosci. 2015; 38(6):364-74. Epub 2015/05/16. S0166-2236(15)00081-8 [pii]. PubMed Central PMCID: PMC4559283. doi:10.1016/j.tins.2015.04.003 PMID: 25975510.
58. Shimizu K, Ogino M, Yamaguchi N, Mitani S, Saito R, Kawase T, et al. Propentofylline (HWA285) inhibits the release of dopamine during transient ischemia and modulates its metabolism in rat striatum. Neurosci Lett. 1993; 158(1):9-12. Epub 1993/08/06. 0304-3940(93)90599-G [pii]. PMID: 8233079.
59. Gough B, Pereira FC, Fontes Ribeiro CA, Ali SF, Binienda ZK. Propentophylline increases striatal dopamine release but dampens methamphetamine-induced dopamine dynamics: A microdialysis study. Neurochem Int. 2014; 76:109-13. Epub 2014/07/23. S0197-0186(14)00159-4 [pii]. doi:10.1016/j.neuint.2014.07.003PMID: 25049173.